IVY Biomedical Cardiac Trigger Monitor Singapore - English - HSA (Health Sciences Authority)

ivy biomedical cardiac trigger monitor

canon medical systems asia pte., ltd. - cardiovascular - the ivy biomedical model 3000 with t‐b option cardiac trigger monitor is intended for monitoring the patient's ecg and heart rate. it is designed for use in the icu, ccu and operating room conditions. it can sound an alarm when the hr falls outside of preset limits. it provides an output pulse, synchronized to the r‐wave for use in applications requiring precision r‐wave synchronization. the model 3000 with t‐b option is limited to use by trained and qualified medical professionals. this product is not intended for home care monitoring.

IVY Biomedical Cardiac Trigger Monitor 7600 Singapore - English - HSA (Health Sciences Authority)

ivy biomedical cardiac trigger monitor 7600

angeion medical international pte. ltd. - cardiovascular - the ivy biomedical model 7000 series cardiac trigger monitors are simple-to-use instruments for monitoring ecg and heart rate. they are designed for use in the icu, ccu and operating room conditions. they can sound an alarm when hr falls outside of the preset limits. they provide an output pulse, synchronised to the r-wave for use in applications requiring precision r-wave synchronisation.

POISON IVY/OAK 1013- poison ivy/oak liquid United States - English - NLM (National Library of Medicine)

poison ivy/oak 1013- poison ivy/oak liquid

professional complementary health formulas - echinacea purpurea 2x adrenal 6x acth 6x, 30x liver 6x, 12x croton tiglium 8x histaminum hydrochloricum 12x kreosotum 12x xerophyllum 12x and all the following at 6x, 12x, 60x, 100x: rhus diversiloba (poison oak) rhus toxicodendron (poison ivy) stinging nettle sumac - for the temporary relief of redness, swelling, stinging, itching of skin, and itching of nose or throat due to sensitivity to poison ivy and poison oak.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Hedelix Cough Syrup 0.8 g/100 ml Syrup Malta - English - Medicines Authority

hedelix cough syrup 0.8 g/100 ml syrup

prohealth limited mdina road zebbug zbg 9019 , malta - syrup - ivy leaves soft extract 0.8 g/100ml - cough and cold preparations

Onivyde 50mg10ml concentrate for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

onivyde 50mg10ml concentrate for solution for infusion vials

baxalta uk ltd - irinotecan hydrochloride trihydrate liposomal pegylated - solution for infusion - 5mg/1ml

Activyl New Zealand - English - Ministry for Primary Industries

activyl

schering-plough animal health limited - indoxacarb - indoxacarb 195 g/litre - ectoparasiticide

ONIVYDE SUSPENSION Canada - English - Health Canada

onivyde suspension

ipsen biopharmaceuticals canada inc - irinotecan (irinotecan sucrose octasulfate) - suspension - 4.3mg - irinotecan (irinotecan sucrose octasulfate) 4.3mg - antineoplastic agents

ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mgmL Singapore - English - HSA (Health Sciences Authority)

onivyde pegylated liposomal (irinotecan) concentrate for dispersion for infusion 4.3 mgml

servier (s) pte ltd - irinotecan (anhydrous free base) - infusion, solution concentrate - irinotecan (anhydrous free base) 4.33 mg/ml

Polivy New Zealand - English - Medsafe (Medicines Safety Authority)

polivy

roche products (nz) ltd - polatuzumab vedotin 30mg - powder for injection - 30 mg - active: polatuzumab vedotin 30mg excipient: polysorbate 20 sodium hydroxide succinic acid sucrose - polivy in combination with rituximab, cyclophosphamide, doxorubicin and prednisone (r-chp), is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma. polivy in combination with bendamustine and rituximab is indicated for the treatment of previously treated adult patients with diffuse large b-cell lymphoma who are not candidates for hematopoietic stem cell transplant.